Current positions and RFPs
Can we optimize the TB response amid funding constraints using evidence-based, cost-effective strategies
An article in a forthcoming issue of IJTLD OPEN examines cost-effective and integrated strategies to sustain and strengthen the TB response in low- and middle-income countries amid declining donor funding.
Laboratory strengthening strategies to advance drug susceptibility testing for BPaL regimens in TB treatment
An article in a forthcoming issue of PHA assesses efforts to strengthen drug susceptibility testing in seven countries to support BPaL rollout, highlighting variable capacity and the need for ongoing training and infrastructure.
Financing the future of TB control: from dependence to resilience
An Editorial in a forthcoming issue of PHA highlights how cuts in donor funding for TB threaten progress but also present an opportunity for governments to invest in resilient, patient-centered health systems. The preprint is free to read.
- Work with a world-renowned scientific organisation
- Receive a tailored induction, training and mentoring
- Collaborate with leading experts
- Experience working in the field
- Help fulfill our vision
- Shape the future of lung health
The Union is an equal opportunities employer. The Union does not discriminate unlawfully on the basis of race, colour, nationality or ethnic origin, gender, disability, marital status, age, religion or belief, sexual orientation or any other condition that cannot be justified.
This applies to all areas of employment including recruitment, hiring, promotion, remuneration, benefits, transfer and learning and development. It is the responsibility of every supervisor and employee to conscientiously follow this policy, and to promote The Union’s Core Values of: Quality, Accountability, Independence and Solidarity.